JOHNSON & JOHNSON Short-Term Debt 2008-2026 | JNJ
Beta
What is short-term debt?
Short-term debt includes borrowings and the current portion of long-term debt due within one year.
What is JOHNSON & JOHNSON's current short-term debt?
JOHNSON & JOHNSON (JNJ) annual short-term debt for 2025 was $8.49B, a 41.99% increase from 2024. JOHNSON & JOHNSON short-term debt for the quarter ending March 29, 2026 was $17.46B.
What was JOHNSON & JOHNSON's short-term debt in 2024?
JOHNSON & JOHNSON annual short-term debt for 2024 was $5.98B, a 73.37% increase from 2023.
What was JOHNSON & JOHNSON's short-term debt in 2023?
JOHNSON & JOHNSON annual short-term debt for 2023 was $3.45B, a 8.36% decline from 2022.
What is JOHNSON & JOHNSON's 4-year short-term debt CAGR?
JOHNSON & JOHNSON short-term debt grew at a compound annual growth rate (CAGR) of 34.05% from FY2021 to FY2025, going from $2.63B to $8.49B over 4 years.
Short-Term Debt History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+47.9%
FY2019
$1.20B
→
FY2025
$8.49B
081011121314161718192122232425
5 years selected
Short-Term Debt History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $8.49B | +42.0% | 10-K |
| FY2024 | $5.98B | +73.4% | 10-K |
| FY2023 | $3.45B | -8.4% | 10-K |
| FY2022 | $3.77B | +43.1% | 10-K |
| FY2021 | $2.63B | +118.9% | 10-K |
| FY2019 | $1.20B | -57.0% | 10-K |
| FY2018 | $2.80B | -28.4% | 10-K |
| FY2017 | $3.91B | -44.2% | 10-K |
| FY2016 | $7.00B | +92.5% | 10-K |
| FY2014 | $3.64B | -25.0% | 10-K |
| FY2013 | $4.85B | +3.8% | 10-K |
| FY2012 | $4.68B | -38.6% | 10-K |
| FY2011 | $7.62B | +20.6% | 10-K |
| FY2010 | $6.32B | +69.3% | 10-K |
| FY2008 | $3.73B | - | 10-K |
Company: JOHNSON & JOHNSONTicker: JNJSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →